Related Experiment Videos
HLA antigens and progression of multiple sclerosis. Part II
Insights
Human Leukocyte Antigen (HLA) types were studied in multiple sclerosis (MS) patients. The HLA-DR2 determinant was more frequent in patients with later MS onset but did not correlate with disease progression or IgG synthesis.
Area of Science:
- Neuroimmunology
- Human Genetics
- Autoimmune Diseases
Background:
- Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
- Human Leukocyte Antigen (HLA) genes are crucial for immune regulation and have been implicated in MS susceptibility.
- Understanding the role of HLA in MS progression is vital for predicting disease course and developing targeted therapies.
Purpose of the Study:
- To investigate the association between HLA-A, -B, -C, and -D alleles and the progression of multiple sclerosis.
- To determine if specific HLA haplotypes correlate with disease onset age, clinical course, and intrathecal immunoglobulin G (IgG) synthesis.
Main Methods:
- HLA typing (HLA-A, -B, -C, -D) was performed on 200 MS patients.
- Disease progression, onset age, clinical course, and cerebrospinal fluid (CSF) parameters (IgG index, oligoclonal bands) were analyzed.
- Statistical correlations were sought between HLA types and clinical/CSF findings.
Main Results:
- No significant correlation was found between HLA haplotypes and MS progression rate or clinical disease course.
- Patients with MS onset after age 31 were more likely to carry the HLA-DR2 determinant (P = 0.016).
- While DR2 carriers showed a higher proportion of elevated IgG index or oligoclonal bands, this difference was not statistically significant compared to non-carriers.
Conclusions:
- HLA haplotypes are not associated with the rate of multiple sclerosis progression or disease course.
- The HLA-DR2 determinant may be linked to a later age of MS onset.
- HLA-DR2 status does not significantly influence intrathecal IgG synthesis in MS patients.
Abstract:
The HLA-A, -B, -C and -D were determined in 200 multiple sclerosis (MS) patients, 64 of whom underwent a CSF examination. Their frequencies were correlated with the rate of disease progression and with factors thought to influence disease progression, including onset age, type of clinical course and intrathecal IgG synthesis. No correlation was found between HLA haplotypes and progression rate or type of disease course. Patients starting MS after age 31 years carried the DR2 determinant more frequently (P = 0.016) than patients with onset before this median age. Although the greatest proportion of patients with an IgG index greater than 1.5 or more than 15 oligoclonal bands in their CSF were DR2 carriers, no statistical difference was found in the intrathecal IgG synthesis of HLA-DR2 (+) and (-) patients.